{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T05:55:31Z","timestamp":1763358931415},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T00:00:00Z","timestamp":1685059200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T00:00:00Z","timestamp":1685059200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the 2020 Li Ka Shing Foundation Cross-Disciplinary Research Grant","award":["2020LKSFG01B"],"award-info":[{"award-number":["2020LKSFG01B"]}]},{"name":"Science and Technology Special Fund of Guangdong Province of China","award":["STKJ202209069"],"award-info":[{"award-number":["STKJ202209069"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Oral tongue squamous cell carcinoma (OTSCC) is one of the most aggressive oral tumors. The aim of this study was to establish a nomogram to predict overall survival (OS) of TSCC patients after surgery. 169 TSCC patients who underwent surgical treatments in the Cancer Hospital of Shantou University Medical College were included. A nomogram based on Cox regression analysis results was established and internally validated using bootstrap resampling method. pTNM stage, age and total protein, immunoglobulin G, factor B and red blood cell count were identified as independent prognostic factors to create the nomogram. The Akaike Information Criterion and Bayesian Information Criterion of the nomogram were lower than those of pTNM stage, indicating a better goodness-of-fit of the nomogram for predicting OS. The bootstrap-corrected concordance index of nomogram was higher than that of pTNM stage (0.794 vs. 0.665,<jats:italic>p<\/jats:italic>\u2009=\u20090.0008). The nomogram also had a good calibration and improved overall net benefit. Based on the cutoff value obtained from the nomogram, the proposed high-risk group had poorer OS than low-risk group (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001). The nomogram based on nutritional and immune-related indicators represents a promising tool for outcome prediction of surgical OTSCC.<\/jats:p>","DOI":"10.1038\/s41598-023-35244-y","type":"journal-article","created":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T10:03:19Z","timestamp":1685095399000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Nutritional and immune-related indicators-based Nomogram for predicting overall survival of surgical oral tongue squamous cell carcinoma"],"prefix":"10.1038","volume":"13","author":[{"given":"Yi-Wei","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Piao","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao-Qun","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin-Liang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi-Han","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Can-Tong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling-Yu","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Peng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang-Cai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,26]]},"reference":[{"issue":"2","key":"35244_CR1","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/hed.24589","volume":"39","author":"JH Ng","year":"2017","unstructured":"Ng, J. H., Iyer, N. G., Tan, M. H. & Edgren, G. Changing epidemiology of oral squamous cell carcinoma of the tongue: A global study. Head Neck. 39(2), 297\u2013304 (2017).","journal-title":"Head Neck."},{"key":"35244_CR2","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.canep.2018.10.014","volume":"57","author":"LW Zhang","year":"2018","unstructured":"Zhang, L. W. et al. Incidence and mortality trends in oral and oropharyngeal cancers in China, 2005\u20132013. Cancer Epidemiol. 57, 120\u2013126 (2018).","journal-title":"Cancer Epidemiol."},{"issue":"5","key":"35244_CR3","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1002\/cam4.1021","volume":"6","author":"Y Li","year":"2017","unstructured":"Li, Y. et al. Nomograms to estimate long-term overall survival and tongue cancer-specific survival of patients with tongue squamous cell carcinoma. Cancer Med. 6(5), 1002\u20131013 (2017).","journal-title":"Cancer Med."},{"issue":"7","key":"35244_CR4","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1002\/hed.23994","volume":"38","author":"M Riemann","year":"2016","unstructured":"Riemann, M. et al. Oral squamous cell carcinoma of the tongue: Prospective and objective speech evaluation of patients undergoing surgical therapy. Head Neck. 38(7), 993\u20131001 (2016).","journal-title":"Head Neck."},{"issue":"6","key":"35244_CR5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.oraloncology.2010.02.015","volume":"46","author":"S Warnakulasuriya","year":"2010","unstructured":"Warnakulasuriya, S. Living with oral cancer: Epidemiology with particular reference to prevalence and life-style changes that influence survival. Oral Oncol. 46(6), 407\u2013410 (2010).","journal-title":"Oral Oncol."},{"issue":"9340","key":"35244_CR6","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/S0140-6736(02)11199-8","volume":"360","author":"H Brenner","year":"2002","unstructured":"Brenner, H. Long-term survival rates of cancer patients achieved by the end of the 20th century: A period analysis. Lancet 360(9340), 1131\u20131135 (2002).","journal-title":"Lancet"},{"issue":"9","key":"35244_CR7","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1002\/cncr.20998","volume":"103","author":"CH Shiboski","year":"2005","unstructured":"Shiboski, C. H., Schmidt, B. L. & Jordan, R. C. Tongue and tonsil carcinoma: Increasing trends in the U.S. population ages 20\u201344 years. Cancer 103(9), 1843\u20131849 (2005).","journal-title":"Cancer"},{"issue":"1","key":"35244_CR8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/hed.23871","volume":"38","author":"A Ebrahimi","year":"2016","unstructured":"Ebrahimi, A. et al. Comparison of the American Joint Committee on Cancer N1 versus N2a nodal categories for predicting survival and recurrence in patients with oral cancer: Time to acknowledge an arbitrary distinction and modify the system. Head Neck. 38(1), 135\u2013139 (2016).","journal-title":"Head Neck."},{"issue":"4","key":"35244_CR9","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/S1470-2045(14)71116-7","volume":"16","author":"VP Balachandran","year":"2015","unstructured":"Balachandran, V. P., Gonen, M., Smith, J. J. & DeMatteo, R. P. Nomograms in oncology: More than meets the eye. Lancet Oncol. 16(4), e173\u2013e180 (2015).","journal-title":"Lancet Oncol."},{"issue":"8","key":"35244_CR10","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1200\/JCO.2007.12.9791","volume":"26","author":"A Iasonos","year":"2008","unstructured":"Iasonos, A., Schrag, D., Raj, G. V. & Panageas, K. S. How to build and interpret a nomogram for cancer prognosis. J. Clin. Oncol. 26(8), 1364\u20131370 (2008).","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"35244_CR11","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S1470-2045(09)70242-6","volume":"10","author":"JS Gold","year":"2009","unstructured":"Gold, J. S. et al. Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: A retrospective analysis. Lancet Oncol. 10(11), 1045\u20131052 (2009).","journal-title":"Lancet Oncol."},{"issue":"13","key":"35244_CR12","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/S1470-2045(13)70491-1","volume":"14","author":"JX Zhang","year":"2013","unstructured":"Zhang, J. X. et al. Prognostic and predictive value of a microRNA signature in stage II colon cancer: A microRNA expression analysis. Lancet Oncol. 14(13), 1295\u20131306 (2013).","journal-title":"Lancet Oncol."},{"issue":"19","key":"35244_CR13","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.1200\/JCO.2003.01.240","volume":"21","author":"MW Kattan","year":"2003","unstructured":"Kattan, M. W., Karpeh, M. S., Mazumdar, M. & Brennan, M. F. Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. J. Clin. Oncol. 21(19), 3647\u20133650 (2003).","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"35244_CR14","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1097\/SLA.0b013e31815ed67b","volume":"247","author":"MW Kattan","year":"2008","unstructured":"Kattan, M. W. et al. A nomogram for predicting disease-specific survival after hepatic resection for metastatic colorectal cancer. Ann Surg. 247(2), 282\u2013287 (2008).","journal-title":"Ann Surg."},{"issue":"3","key":"35244_CR15","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/cncr.26333","volume":"118","author":"O Zivanovic","year":"2012","unstructured":"Zivanovic, O. et al. A nomogram to predict postresection 5-year overall survival for patients with uterine leiomyosarcoma. Cancer 118(3), 660\u2013669 (2012).","journal-title":"Cancer"},{"key":"35244_CR16","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1186\/1471-2407-14-654","volume":"14","author":"L Yang","year":"2014","unstructured":"Yang, L., Takimoto, T. & Fujimoto, J. Prognostic model for predicting overall survival in children and adolescents with rhabdomyosarcoma. BMC Cancer 14, 654 (2014).","journal-title":"BMC Cancer"},{"key":"35244_CR17","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1111\/coa.13102","volume":"43","author":"M Graupp","year":"2018","unstructured":"Graupp, M. et al. C-reactive protein is an independent prognostic marker in patients with tongue carcinoma\u2014a retrospective study. Clin. Otolaryngol. 43, 1050\u20131056 (2018).","journal-title":"Clin. Otolaryngol."},{"issue":"3","key":"35244_CR18","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.suronc.2018.06.002","volume":"27","author":"V Abbate","year":"2018","unstructured":"Abbate, V. et al. Pre-treatment Neutrophil-to-Lymphocyte Ratio as a predictor for occult cervical metastasis in early stage (T1\u2013T2 cN0) squamous cell carcinoma of the oral tongue. Surg. Oncol. 27(3), 503\u2013507 (2018).","journal-title":"Surg. Oncol."},{"key":"35244_CR19","doi-asserted-by":"publisher","first-page":"3917","DOI":"10.2147\/OTT.S140800","volume":"10","author":"CN Wu","year":"2017","unstructured":"Wu, C. N. et al. Prognosis of neutrophil-to-lymphocyte ratio in clinical early-stage tongue (cT1\/T2N0) cancer. Onco Targets Ther. 10, 3917\u20133924 (2017).","journal-title":"Onco Targets Ther."},{"issue":"1","key":"35244_CR20","doi-asserted-by":"publisher","first-page":"405","DOI":"10.21873\/anticanres.13126","volume":"39","author":"K Furukawa","year":"2019","unstructured":"Furukawa, K., Kawasaki, G., Naruse, T. & Umeda, M. Prognostic significance of pretreatment lymphocyte-to-monocyte ratio in patients with tongue cancer. Anticancer Res. 39(1), 405\u2013412 (2019).","journal-title":"Anticancer Res."},{"issue":"26","key":"35244_CR21","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000016206","volume":"98","author":"W Sun","year":"2019","unstructured":"Sun, W. et al. Nomograms to predict survival of stage IV tongue squamous cell carcinoma after surgery. Med. (Baltim.) 98(26), e16206 (2019).","journal-title":"Med. (Baltim.)"},{"issue":"1","key":"35244_CR22","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1186\/s12885-021-08135-6","volume":"21","author":"P Saenthaveesuk","year":"2021","unstructured":"Saenthaveesuk, P. et al. Development and validation of multiparametric MRI-based nomogram for predicting occult metastasis risk in early tongue squamous cell carcinoma. BMC Cancer 21(1), 408 (2021).","journal-title":"BMC Cancer"},{"issue":"8","key":"35244_CR23","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1002\/hed.25161","volume":"40","author":"M Mair","year":"2018","unstructured":"Mair, M. et al. Comparison of tumor volume, thickness, and T classification as predictors of outcomes in surgically treated squamous cell carcinoma of the oral tongue. Head Neck 40(8), 1667\u20131675 (2018).","journal-title":"Head Neck"},{"issue":"4","key":"35244_CR24","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1002\/hed.26554","volume":"43","author":"D Balasubramanian","year":"2021","unstructured":"Balasubramanian, D. et al. Predictive nomograms for oral tongue squamous cell carcinoma applying the American Joint Committee on Cancer\/Union Internationale Contre le Cancer 8th edition staging system. Head Neck 43(4), 1043\u20131055 (2021).","journal-title":"Head Neck"},{"key":"35244_CR25","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1016\/j.joms.2021.04.010","volume":"79","author":"F Huang","year":"2021","unstructured":"Huang, F., Xu, G. & Du, H. A new nomogram for predicting overall survival and assisting postoperative adjuvant treatment decision-making in stage II oral tongue squamous cell carcinoma: A surveillance, epidemiology and end results (SEER) database analysis. J. Oral Maxillofac. Surg. 79, 2147\u20132154 (2021).","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"12","key":"35244_CR26","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.7150\/jca.24530","volume":"9","author":"B Chang","year":"2018","unstructured":"Chang, B. et al. A prognostic nomogram incorporating depth of tumor invasion to predict long-term overall survival for tongue squamous cell carcinoma with R0 resection. J. Cancer. 9(12), 2107\u20132115 (2018).","journal-title":"J. Cancer."},{"issue":"5","key":"35244_CR27","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1111\/his.14202","volume":"77","author":"M Mascitti","year":"2020","unstructured":"Mascitti, M., Zhurakivska, K., Togni, L., Caponio, V. C. A. & Almangush, A. Addition of the tumour-stroma ratio to the 8th edition American Joint Committee on Cancer staging system improves survival prediction for patients with oral tongue squamous cell carcinoma. Histopathology 77(5), 810\u2013822 (2020).","journal-title":"Histopathology"},{"issue":"10","key":"35244_CR28","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.bjoms.2019.09.024","volume":"57","author":"Q Jiang","year":"2019","unstructured":"Jiang, Q. et al. Development and validation of a nomogram to predict the risk of occult cervical lymph node metastases in cN0 squamous cell carcinoma of the tongue. Br. J. Oral Maxillofac. Surg. 57(10), 1092\u20131097 (2019).","journal-title":"Br. J. Oral Maxillofac. Surg."},{"issue":"2","key":"35244_CR29","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21388","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin, M. B. et al. The eighth edition AJCC cancer staging manual: Continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging. CA Cancer J. Clin. 67(2), 93\u201399 (2017).","journal-title":"CA Cancer J. Clin."},{"issue":"21","key":"35244_CR30","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","volume":"10","author":"RL Camp","year":"2004","unstructured":"Camp, R. L., Dolled-Filhart, M. & Rimm, D. L. X-tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin. Cancer Res. 10(21), 7252\u20137259 (2004).","journal-title":"Clin. Cancer Res."},{"key":"35244_CR31","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3389\/fonc.2020.00341","volume":"10","author":"Z Lu","year":"2020","unstructured":"Lu, Z. et al. Nomogram based on systemic immune-inflammation index to predict survival of tongue cancer patients who underwent cervical dissection. Front Oncol. 10, 341 (2020).","journal-title":"Front Oncol."},{"issue":"11","key":"35244_CR32","doi-asserted-by":"publisher","first-page":"e493","DOI":"10.1016\/S1470-2045(14)70263-3","volume":"15","author":"CI Diakos","year":"2014","unstructured":"Diakos, C. I., Charles, K. A., McMillan, D. C. & Clarke, S. J. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 15(11), e493-503 (2014).","journal-title":"Lancet Oncol."},{"key":"35244_CR33","doi-asserted-by":"publisher","first-page":"155522","DOI":"10.1016\/j.cyto.2021.155522","volume":"143","author":"P Lu","year":"2021","unstructured":"Lu, P., Ma, Y., Wei, S. & Liang, X. The dual role of complement in cancers, from destroying tumors to promoting tumor development. Cytokine 143, 155522 (2021).","journal-title":"Cytokine"},{"issue":"11","key":"35244_CR34","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1158\/1541-7786.MCR-10-0225","volume":"8","author":"MJ Rutkowski","year":"2010","unstructured":"Rutkowski, M. J., Sughrue, M. E., Kane, A. J., Mills, S. A. & Parsa, A. T. Cancer and the complement cascade. Mol. Cancer Res. 8(11), 1453\u20131465 (2010).","journal-title":"Mol. Cancer Res."},{"issue":"12","key":"35244_CR35","doi-asserted-by":"publisher","first-page":"5315","DOI":"10.1021\/acs.jproteome.1c00805","volume":"20","author":"MJ Lee","year":"2021","unstructured":"Lee, M. J. et al. Early diagnostic ability of human complement factor B in pancreatic cancer is partly linked to its potential tumor-promoting role. J. Prot. Res. 20(12), 5315\u20135328 (2021).","journal-title":"J. Prot. Res."},{"issue":"4","key":"35244_CR36","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s13402-021-00614-z","volume":"44","author":"R Shimazaki","year":"2021","unstructured":"Shimazaki, R. et al. Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer. Cell Oncol. (Dordr). 44(4), 937\u2013950 (2021).","journal-title":"Cell Oncol. (Dordr)."},{"key":"35244_CR37","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s13402-021-00614-z","volume":"44","author":"R Shimazaki","year":"2021","unstructured":"Shimazaki, R. et al. Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer. Cell Oncol. (Dordr). 44, 937\u2013950 (2021).","journal-title":"Cell Oncol. (Dordr)."},{"issue":"5","key":"35244_CR38","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.ajpath.2017.01.006","volume":"187","author":"P Riihil\u00e4","year":"2017","unstructured":"Riihil\u00e4, P. et al. Complement component C3 and complement factor B promote growth of cutaneous squamous cell carcinoma. Am. J. Pathol. 187(5), 1186\u20131197 (2017).","journal-title":"Am. J. Pathol."},{"issue":"2","key":"35244_CR39","doi-asserted-by":"publisher","first-page":"12854","DOI":"10.1080\/21655979.2021.2005745","volume":"12","author":"P Wu","year":"2021","unstructured":"Wu, P., Shi, J., Sun, W. & Zhang, H. The prognostic value of plasma complement factor B (CFB) in thyroid carcinoma. Bioengineered 12(2), 12854\u201312866 (2021).","journal-title":"Bioengineered"},{"issue":"21","key":"35244_CR40","doi-asserted-by":"publisher","first-page":"11597","DOI":"10.3390\/ijms222111597","volume":"22","author":"S Kdimati","year":"2021","unstructured":"Kdimati, S., Mullins, C. S. & Linnebacher, M. Cancer-cell-derived igg and its potential role in tumor development. Int. J. Mol. Sci. 22(21), 11597 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"35244_CR41","doi-asserted-by":"publisher","first-page":"748","DOI":"10.21037\/atm-20-3504","volume":"8","author":"S Lin","year":"2020","unstructured":"Lin, S. et al. Serum immunoglobulin G N-glycome: A potential biomarker in endometrial cancer. Ann. Transl. Med. 8(12), 748 (2020).","journal-title":"Ann. Transl. Med."},{"issue":"12","key":"35244_CR42","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2015.1011503","volume":"4","author":"CH Yi","year":"2015","unstructured":"Yi, C. H. et al. Elevated core-fucosylated IgG is a new marker for hepatitis B virus-related hepatocellular carcinoma. Oncoimmunology. 4(12), e1011503 (2015).","journal-title":"Oncoimmunology."},{"issue":"12","key":"35244_CR43","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1158\/1078-0432.CCR-15-1867","volume":"22","author":"F Vu\u010dkovi\u0107","year":"2016","unstructured":"Vu\u010dkovi\u0107, F. et al. IgG glycome in colorectal cancer. Clin. Cancer Res. 22(12), 3078\u20133086 (2016).","journal-title":"Clin. Cancer Res."},{"key":"35244_CR44","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cellimm.2018.07.009","volume":"333","author":"I Gudelj","year":"2018","unstructured":"Gudelj, I., Lauc, G. & Pezer, M. Immunoglobulin G glycosylation in aging and diseases. Cell Immunol. 333, 65\u201379 (2018).","journal-title":"Cell Immunol."},{"issue":"3","key":"35244_CR45","doi-asserted-by":"publisher","first-page":"499","DOI":"10.21147\/j.issn.1000-9604.2019.03.12","volume":"31","author":"H Jiang","year":"2019","unstructured":"Jiang, H. et al. Cancer IgG, a potential prognostic marker, promotes colorectal cancer progression. Chin. J. Cancer Res. 31(3), 499\u2013510 (2019).","journal-title":"Chin. J. Cancer Res."},{"issue":"8","key":"35244_CR46","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.7150\/jca.39800","volume":"11","author":"M Cui","year":"2020","unstructured":"Cui, M. et al. High expression of cancer-derived glycosylated immunoglobulin g predicts poor prognosis in pancreatic ductal adenocarcinoma. J. Cancer. 11(8), 2213\u20132221 (2020).","journal-title":"J. Cancer."},{"key":"35244_CR47","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3389\/fonc.2020.00263","volume":"10","author":"S Sollie","year":"2020","unstructured":"Sollie, S. et al. Serum immunoglobulin G is associated with decreased risk of pancreatic cancer in the Swedish AMORIS study. Front Oncol. 10, 263 (2020).","journal-title":"Front Oncol."},{"key":"35244_CR48","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.3389\/fonc.2019.01095","volume":"9","author":"A Kessler","year":"2019","unstructured":"Kessler, A. et al. Serum IgG is associated with risk of melanoma in the Swedish AMORIS study. Front Oncol. 9, 1095 (2019).","journal-title":"Front Oncol."},{"issue":"2","key":"35244_CR49","doi-asserted-by":"publisher","first-page":"119","DOI":"10.33160\/yam.2017.06.008","volume":"60","author":"H Saito","year":"2017","unstructured":"Saito, H. et al. Decreased serum concentration of total IgG is related to tumor progression in gastric cancer patients. Yonago Acta Med. 60(2), 119\u2013125 (2017).","journal-title":"Yonago Acta Med."},{"issue":"3","key":"35244_CR50","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4251\/wjgo.v11.i3.195","volume":"11","author":"ZH Geng","year":"2019","unstructured":"Geng, Z. H. et al. Human colorectal cancer cells frequently express IgG and display unique Ig repertoire. World J. Gastrointest. Oncol. 11(3), 195\u2013207 (2019).","journal-title":"World J. Gastrointest. Oncol."},{"issue":"Suppl 2","key":"35244_CR51","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1016\/j.ejon.2005.09.001","volume":"9","author":"M von Meyenfeldt","year":"2005","unstructured":"von Meyenfeldt, M. Cancer-associated malnutrition: an introduction. Eur. J. Oncol. Nurs. 9(Suppl 2), S35\u2013S38 (2005).","journal-title":"Eur. J. Oncol. Nurs."},{"key":"35244_CR52","doi-asserted-by":"publisher","first-page":"10849","DOI":"10.2147\/CMAR.S271078","volume":"12","author":"Y Tong","year":"2020","unstructured":"Tong, Y. et al. Low red blood cell count as an early indicator for myometrial invasion in women with endometrioid endometrial carcinoma with metabolic syndrome. Cancer Manag. Res. 12, 10849\u201310859 (2020).","journal-title":"Cancer Manag. Res."},{"issue":"8","key":"35244_CR53","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1002\/ijc.33351","volume":"148","author":"MM He","year":"2021","unstructured":"He, M. M. et al. Circulating liver function markers and colorectal cancer risk: A prospective cohort study in the UK Biobank. Int J Cancer. 148(8), 1867\u20131878 (2021).","journal-title":"Int J Cancer."},{"issue":"5","key":"35244_CR54","first-page":"460","volume":"15","author":"YP Du","year":"2012","unstructured":"Du, Y. P. et al. Nutritional risk screening and nutrition assessment for gastrointestinal cancer patients. Zhonghua Wei Chang Wai Ke Za Zhi 15(5), 460\u2013463 (2012).","journal-title":"Zhonghua Wei Chang Wai Ke Za Zhi"},{"issue":"2","key":"35244_CR55","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0167-8140(01)00326-7","volume":"59","author":"VN Bhattathiri","year":"2001","unstructured":"Bhattathiri, V. N. Relation of erythrocyte and iron indices to oral cancer growth. Radiother Oncol. 59(2), 221\u2013226 (2001).","journal-title":"Radiother Oncol."},{"issue":"6","key":"35244_CR56","doi-asserted-by":"publisher","first-page":"967","DOI":"10.7150\/jca.18000","volume":"8","author":"F Peng","year":"2017","unstructured":"Peng, F. et al. The monocyte to red blood cell count ratio is a strong predictor of postoperative survival in colorectal cancer patients: The Fujian prospective investigation of cancer (FIESTA) study. J. Cancer 8(6), 967\u2013975 (2017).","journal-title":"J. Cancer"},{"issue":"13","key":"35244_CR57","doi-asserted-by":"publisher","first-page":"3834","DOI":"10.7150\/jca.42409","volume":"11","author":"Y Li","year":"2020","unstructured":"Li, Y. et al. Prognostic evaluation of colorectal cancer using three new comprehensive indexes related to infection, anemia and coagulation derived from peripheral blood. J. Cancer 11(13), 3834\u20133845 (2020).","journal-title":"J. Cancer"},{"issue":"8","key":"35244_CR58","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000577","volume":"94","author":"X Xie","year":"2015","unstructured":"Xie, X. et al. Reduced red blood cell count predicts poor survival after surgery in patients with primary liver cancer. Med. (Baltim.) 94(8), e577 (2015).","journal-title":"Med. (Baltim.)"},{"issue":"4","key":"35244_CR59","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1053\/ctrv.2000.0181","volume":"26","author":"S Mercadante","year":"2000","unstructured":"Mercadante, S., Gebbia, V., Marrazzo, A. & Filosto, S. Anaemia in cancer: Pathophysiology and treatment. Cancer Treat. Rev. 26(4), 303\u2013311 (2000).","journal-title":"Cancer Treat. Rev."},{"issue":"4","key":"35244_CR60","first-page":"3666","volume":"13","author":"Y Wang","year":"2021","unstructured":"Wang, Y. & Zhou, Q. The effect of accelerated rehabilitation nursing on postoperative recovery, nutritional status, and psychological status in patients with gastric cancer. Am. J. Transl. Res. 13(4), 3666\u20133673 (2021).","journal-title":"Am. J. Transl. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35244-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35244-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35244-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T03:41:34Z","timestamp":1702525294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35244-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,26]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["35244"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-35244-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,26]]},"assertion":[{"value":"3 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8525"}}